Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distribution.
Ontology highlight
ABSTRACT: An accurate diagnostic method using biological indicators is critically needed for bipolar disorder (BD) and major depressive disorder (MDD). The excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is a crucial regulator of synaptic function, and its dysregulation may play a central role in the pathophysiology of psychiatric disorders. Our recently developed positron emission tomography (PET) tracer, [11C]K-2, enables the quantitative visualization of AMPAR distribution and is considered useful for characterizing synaptic phenotypes in patients with psychiatric disorders. This study aimed to develop a machine learning-based method to differentiate bipolar disorder from major depressive disorder using AMPAR density. Sixteen patients with BD
SUBMITTER: Tsugawa S
PROVIDER: S-EPMC12358400 | biostudies-literature | 2025
REPOSITORIES: biostudies-literature
ACCESS DATA